Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

被引：0
|
作者：
Giuseppe Bronte
Andrea Rocca
Sara Ravaioli
Maurizio Puccetti
Maria Maddalena Tumedei
Emanuela Scarpi
Daniele Andreis
Roberta Maltoni
Samanta Sarti
Lorenzo Cecconetto
Anna Fedeli
Elisabetta Pietri
Valeria De Simone
Silvia Asioli
Dino Amadori
Sara Bravaccini
机构：
[1] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,Department of Pathology
[2] S. Maria delle Croci Hospital,undefined
[3] Morgagni-Pierantoni Hospital,undefined
来源：
BMC Cancer | / 18卷
关键词：
Androgen receptor; Advanced breast cancer; Anti-estrogen therapy; Endocrine therapy; AR/ER ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
    Bronte, Giuseppe
    Rocca, Andrea
    Ravaioli, Sara
    Puccetti, Maurizio
    Tumedei, Maria Maddalena
    Scarpi, Emanuela
    Andreis, Daniele
    Maltoni, Roberta
    Sarti, Samanta
    Cecconetto, Lorenzo
    Pietri, Elisabetta
    De Simone, Valeria
    Asioli, Silvia
    Amadori, Dino
    Bravaccini, Sara
    BMC CANCER, 2018, 18
  • [2] Is androgen receptor useful to predict the efficacy of anti-estrogen therapy in advanced breast cancer?
    Rocca, Andrea
    Bronte, Giuseppe
    Ravaioli, Sara
    Puccetti, Maurizio
    Tumedei, Maria Maddalena
    Scarpi, Emanuela
    Maltoni, Roberta
    Sarti, Samanta
    Cecconetto, Lorenzo
    Bedei, Lucia
    Fedeli, Anna
    Andreis, Daniele
    Pietri, Elisabetta
    Calistri, Daniele
    Amadori, Dino
    Bravaccini, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Quantitative Progesterone Receptor Expression and Efficacy of Anti-estrogen Therapy in Breast Cancer
    Luoh, Shiuh-Wen
    Ramsey, Betsy
    Park, Byung
    Keenan, Edward
    BREAST JOURNAL, 2014, 20 (01): : 46 - 52
  • [4] INTERMITTENT ANTI-ESTROGEN THERAPY IN ADVANCED BREAST-CANCER
    STOLL, BA
    CANCER TREATMENT REPORTS, 1983, 67 (01): : 98 - 98
  • [5] THE ANTI-ESTROGEN TAMOXIFEN IN ADVANCED BREAST-CANCER
    MARGREITER, R
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1980, 351 (04): : 249 - 262
  • [6] Pathologic Changes in Breast Cancer After Anti-Estrogen Therapy
    Samarnthai, Norasate
    Elledge, Richard
    Prihoda, Thomas J.
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    BREAST JOURNAL, 2012, 18 (04): : 362 - 366
  • [7] Pathologic changes in breast cancer after anti-estrogen therapy
    Samarnthai, Norasate
    Elledge, Richard
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    FASEB JOURNAL, 2010, 24
  • [8] Breast Density Change as a Predictive Surrogate of Adjuvant Anti-estrogen Therapy Response in Estrogen Receptor Positive Breast Cancer
    Kim, J. S.
    Han, W.
    You, J. M.
    Shin, H. C.
    Ahn, S. K.
    Moon, H. G.
    Noh, D. Y.
    Cho, N.
    Moon, W. K.
    Park, I. A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S133 - S133
  • [9] Un"Abl"ing Anti-estrogen Therapy Resistance in Estrogen Receptor-alpha Positive Breast Cancer
    Cook, K. L.
    Schwartz, J. L.
    Facey, C. O. B.
    Jin, L.
    Zwart, A.
    Abu-Azab, M.
    Warri, A.
    Clarke, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 26 - 26
  • [10] Estrogen regulated oncogene SHON mediates the efficacy of anti-estrogen treatment in breast cancer
    Xu, Bing
    Jung, Yewon
    Perry, Jo
    Zhu, Tao
    Lobie, Peter E.
    Huang, Baiqu
    Lu, Jun
    Liu, Dong-Xu
    CANCER RESEARCH, 2014, 74 (19)
12345